Wolverine Trading, LLC Viking Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$49.84 - $70.47 $4.41 Million - $6.23 Million	88,400 Added 83.87%	193,800 $12.3 Million
Q2 2024 Aug 14, 2024	SELL	$47.39 - $80.2 $1.82 Million - $3.09 Million	-38,500 Reduced 26.75%	105,400 $5.59 Million
Q1 2024 May 15, 2024	BUY	$17.4 - $94.5 $1.01 Million - $5.46 Million	57,800 Added 67.13%	143,900 $11.8 Million
Q4 2023 Feb 14, 2024	BUY	$9.24 - $19.64 $232,848 - $494,928	25,200 Added 41.38%	86,100 $1.6 Million
Q3 2023 Nov 15, 2023	SELL	$10.92 - $16.0 $566,748 - $830,400	-51,900 Reduced 46.01%	60,900 $674,000
Q2 2023 Aug 23, 2023	BUY	$14.84 - $24.79 $230,020 - $384,245	15,500 Added 15.93%	112,800 $1.83 Million
Q1 2023 May 15, 2023	BUY	$8.08 - $17.33 $54,136 - $116,110	6,700 Added 7.4%	97,300 $1.69 Million
Q4 2022 Feb 14, 2023	BUY	$2.72 - $9.4 $246,432 - $851,640	90,600 New	90,600 $852,000
Q2 2022 Aug 15, 2022	BUY	$2.11 - $3.15 $48,319 - $72,135	22,900 Added 216.04%	33,500 $93,000
Q1 2022 May 16, 2022	SELL	$3.0 - $4.88 $31,800 - $51,728	-10,600 Reduced 50.0%	10,600 $32,000
Q4 2021 Feb 14, 2022	BUY	$4.6 - $6.72 $97,519 - $142,464	21,200 New	21,200 $98,000
Q3 2021 Nov 12, 2021	SELL	$5.58 - $7.04 $108,252 - $136,576	-19,400 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$5.19 - $6.73 $84,597 - $109,699	-16,300 Reduced 45.66%	19,400 $120,000
Q1 2021 May 14, 2021	BUY	$5.74 - $9.67 $204,918 - $345,219	35,700 New	35,700 $216,000
Q4 2020 Feb 12, 2021	SELL	$5.3 - $6.71 $326,480 - $413,336	-61,600 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$5.73 - $8.11 $126,633 - $179,231	-22,100 Reduced 26.4%	61,600 $365,000
Q2 2020 Aug 13, 2020	BUY	$4.35 - $8.08 $38,280 - $71,104	8,800 Added 11.75%	83,700 $608,000
Q1 2020 May 11, 2020	BUY	$3.45 - $7.95 $258,405 - $595,455	74,900 New	74,900 $355,000
Q4 2019 Feb 12, 2020	SELL	$6.38 - $8.73 $717,750 - $982,125	-112,500 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$6.55 - $8.6 $736,875 - $967,500	112,500 New	112,500 $781,000
Q1 2019 May 15, 2019	SELL	$7.58 - $9.94 $860,330 - $1.13 Million	-113,500 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$7.16 - $16.21 $168,260 - $380,935	-23,500 Reduced 17.15%	113,500 $859,000
Q3 2018 Nov 14, 2018	BUY	$9.7 - $19.65 $1.33 Million - $2.69 Million	137,000 New	137,000 $2.39 Million

Others Institutions Holding VKTX

# of Institutions

473

Shares Held

65.6M

Call Options Held

5.72M

Put Options Held

3.39M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.25B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account